| Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma M Pertesi, M Vallée, X Wei, MV Revuelta, P Galia, D Demangel, J Oliver, ... Leukemia 33 (9), 2324-2330, 2019 | 42 | 2019 |
| Characteristics and outcomes of patients with multiple myeloma aged 21–40 years versus 41–60 years: a multi‐institutional case‐control study A Jurczyszyn, H Nahi, I Avivi, A Gozzetti, R Niesvizky, S Yadlapati, ... British Journal of Haematology 175 (5), 884-891, 2016 | 39 | 2016 |
| Response to anti‐SARS‐CoV‐2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients J Zaleska, P Kwasnik, M Paziewska, J Purkot, A Szabelak, M Jurek, ... International Journal of Cancer 152 (4), 705-712, 2023 | 26 | 2023 |
| Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study E Kalicińska, D Szymczak, I Andrasiak, A Bogucka-Fedorczuk, A Zińczuk, ... Translational Oncology 14 (1), 100943, 2021 | 20 | 2021 |
| Endothelial activation and stress index (EASIX) as an early Predictor for mortality and overall survival in hematological and non-hematological patients with COVID-19 … E Kalicińska, M Biernat, J Rybka, A Zińczuk, J Janocha-Litwin, ... Journal of Clinical Medicine 10 (19), 4373, 2021 | 19 | 2021 |
| Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients A Macauda, E Castelli, G Buda, M Pelosini, A Butrym, M Watek, ... British Journal of Haematology 183 (3), 375-384, 2018 | 18 | 2018 |
| Genetically determined telomere length and multiple myeloma risk and outcome M Giaccherini, A Macauda, E Orciuolo, M Rymko, K Gruenpeter, ... Blood cancer journal 11 (4), 74, 2021 | 15 | 2021 |
| Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study D Campa, A Martino, A Macauda, M Dudziński, A Suska, A Druzd-Sitek, ... Leukemia & lymphoma 60 (7), 1803-1811, 2019 | 15 | 2019 |
| Identification of miRSNPs associated with the risk of multiple myeloma A Macauda, D Calvetti, G Maccari, K Hemminki, A Försti, H Goldschmidt, ... International journal of cancer 140 (3), 526-534, 2017 | 12 | 2017 |
| A polygenic risk score for multiple myeloma risk prediction F Canzian, C Piredda, A Macauda, D Zawirska, NF Andersen, A Nagler, ... European Journal of Human Genetics 30 (4), 474-479, 2022 | 10 | 2022 |
| Real-life experience with bortezomib-based regimens in elderly patients with newly diagnosed multiple myeloma and comorbidities: A Polish retrospective multicenter study I Hus, A Walter-Croneck, A Masternak, A Jurczyszyn, ... Pol Arch Intern Med 127 (11), 765-774, 2017 | 9 | 2017 |
| Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective—a report by Polish Myeloma Study Group A Walter-Croneck, N Grzasko, M Soroka-Wojtaszko, A Jurczyszyn, ... Leukemia Research 38 (7), 788-794, 2014 | 7 | 2014 |
| Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients A Macauda, C Piredda, AI Clay‐Gilmour, J Sainz, G Buda, M Markiewicz, ... International journal of cancer 149 (2), 327-336, 2021 | 6 | 2021 |
| Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients—Report of the Polish Myeloma Group L Usnarska-Zubkiewicz, J Dębski, A Butrym, W Legieć, M Hus, ... Leukemia Research 40, 90-99, 2016 | 6 | 2016 |
| Common gene variants within 3′‐untranslated regions as modulators of multiple myeloma risk and survival O Melaiu, A Macauda, J Sainz, D Calvetti, MS Facioni, G Maccari, ... International Journal of Cancer 148 (8), 1887-1894, 2021 | 5 | 2021 |
| Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with … E Iskierka-Jażdżewska, F Canzian, A Stępień, A Martino, D Campa, ... Leukemia & lymphoma 61 (3), 699-706, 2020 | 5 | 2020 |
| Cereblon (CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A … E Iskierka-Jazdzewska, A Stepien, F Canzian, A Martino, D Campa, ... Blood, The Journal of the American Society of Hematology 124 (21), 3628-3628, 2014 | 5 | 2014 |
| Dynamics of Stomach Growth in the Human Fetal Period–a Postmortem Study B Gworys, S Jeka, R Brukiewa, M Rymko International Journal of Morphology 30 (2), 461-466, 2012 | 5* | 2012 |
| Does a multiple myeloma polygenic risk score predict overall survival of patients with myeloma? A Macauda, A Clay-Gilmour, T Hielscher, MAT Hildebrandt, M Kruszewski, ... Cancer Epidemiology, Biomarkers & Prevention 31 (9), 1863-1866, 2022 | 4 | 2022 |
| Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical … AM Madejczyk, F Canzian, J Gora-Tybor, D Campa, T Sacha, ... Frontiers in Oncology 12, 952640, 2022 | 3 | 2022 |
